Interferon alpha-2b biosimilar (Zydus Cadila)

干扰素α-2b生物类似药 (Zydus Cadila)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-2b biosimilar (Zydus Cadila)
Drug Alias NameIFNα-2b干扰素α-2b生物仿制药 (Zydus Cadila)IFNα-2b (Zydus Cadila)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis BCondylomata Acuminata
Global Approved IndicationsHepatitis CHepatitis BCondylomata Acuminata
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2014/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZydus Cadila
China Registration ClassN/A

Develop Information

Active CompaniesZydus Cadila
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis BCondylomata Acuminata
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A